| 产品详情 |
| Edit |   |
|---|
| Product Name | (±)14(15)-EpETE |
|---|
| Description | EDHF is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (NO) and COX-derived (prostacyclin) vasodilators.{6485,7204} CYP450 metabolism of PUFAs, produces epoxides such as (±)14(15)-EpETrE which are prime candidates for the actual active mediator.{5826} However, the CYP450 metabolites of EPA (Item No. 90110) and DHA (Item No. 90310) have been little studied relative to arachidonate epoxygenase metabolites. (±)14(15)-EpETE is the ω-3 homolog of (±)14(15)-EpETrE, derived via epoxidation of the 14,15-double bond of EPA. The EDHF activity of (±)14(15)-EpETE has not yet been determined. |
|---|
| Size | 100 µg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (±)14,15 EEQ|(±)14,15-epoxy Eicosatetraenoic Acid |
|---|
| Gene, Accession, CAS # | CAS: 131339-24-7 |
|---|
| Catalog # | 10173-100 |
|---|
| Price | |
|---|
| Order / More Info | (±)14(15)-EpETE from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|